New poly-imidazolium-triazole particles by CuAAC cross-linking of calix[4]arene bis-azide/alkyne amphiphiles - a prospective support for Pd in the Mizoroki-Heck reaction.
Vladimir A BurilovRamilya GaripovaDiana A MironovaElza D SultanovaIlshat BogdanovEvgeny OcherednyukVladimir EvtugynYuri OsinIldar RizvanovSvetlana SolovievaIgor S AntipinPublished in: RSC advances (2020)
A new imidazolium amphiphilic calix[4]arene with terminal acetylene fragments in the polar region was synthesized according to a two step scheme including regioselective chloromethylation of distal di- O -butyl calix[4]arene and subsequent interaction with 1-(hex-5-yn-1-yl)-1 H -imidazole. The aggregation properties (CAC, the size and zeta potential of aggregates) of alkynyl calix[4]arene as well as of previously synthesized azidopropyl calix[4]arene and their 1 : 1 mixture were disclosed. Macrocycles with azide and alkyne fragments in the polar region were covalently cross-linked under CuAAC conditions in water. Successful cross-linking of molecules has been proven by IR spectroscopy and MALDI-TOF spectrometry. The obtained polymeric particles were studied both in solution and the solid state and the presence of submicron (∼200 nm) and micron (∼1-5 μm) particles with the prevalence of the latter was found. The average molecular weight of the polymer according to the static light scattering data was found to be 639 ± 44 kDa. The obtained polymeric imidazolium-triazole particles were tested as a support for Pd(OAc) 2 in the Mizoroki-Heck reaction carried out in both organic and water media. In both solvents (especially in water) the addition of imidazolium-triazole particles to Pd(OAc) 2 increased the conversion of 4-iodanisole. It was found that the ratio between the products (1,1 and 1,2-substituted ethylenes) changes drastically on going from DMF to water from 1 : 5 to 1 : 40 when using supported Pd(OAc) 2 .
Keyphrases
- ionic liquid
- solid state
- water soluble
- mass spectrometry
- drug delivery
- high resolution
- ms ms
- risk assessment
- risk factors
- drug release
- minimally invasive
- escherichia coli
- photodynamic therapy
- machine learning
- big data
- electronic health record
- molecular docking
- artificial intelligence
- heat shock protein
- deep learning
- staphylococcus aureus
- climate change
- human health
- single molecule
- biofilm formation